These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2839325)

  • 1. Binding profile of trazodone and dapiprazole to some brain receptors.
    Valeri P; Palmery M; Silvestrini B
    Drugs Exp Clin Res; 1988; 14(1):53-8. PubMed ID: 2839325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
    Kendall DA; Taylor DP; Enna SJ
    Mol Pharmacol; 1983 May; 23(3):594-9. PubMed ID: 6865906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The existence on the serotonin carrier of 2 independent sites for the specific binding of trazodone and imizin].
    Katanasov AB; Brusov OS
    Farmakol Toksikol; 1988; 51(6):32-5. PubMed ID: 2976683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
    Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
    Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding profile of tibalosine, a new antihypertensive.
    Chatelain P; Friedhoff AJ; Meller E; Mennini T; Gorissen H; Roba J
    Arzneimittelforschung; 1984; 34(7):754-8. PubMed ID: 6093823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors.
    Muller P; Seeman P
    Life Sci; 1977 Dec; 21(12):1751-8. PubMed ID: 203807
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E; Bagdas D; Gurun MS
    Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the receptor profile of bisoprolol.
    Klockow M; Greiner HE; Haase A; Schmitges CJ; Seyfried C
    Arzneimittelforschung; 1986 Feb; 36(2):197-200. PubMed ID: 2870719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptors.
    Seeman P; Kapur S
    Synapse; 2003 Oct; 50(1):35-40. PubMed ID: 12872292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors.
    Berzétei IP; Bagdy E; Hardy M; Borsy J
    Pol J Pharmacol Pharm; 1985; 37(3):237-42. PubMed ID: 4070077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
    Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K
    Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB; Battaglia G; Creese I
    Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO] for dopamine receptors in vitro and in vivo.
    Martin GE; Williams M; Pettibone DJ; Zrada MM; Lotti VJ; Taylor DA; Jones JH
    J Pharmacol Exp Ther; 1985 May; 233(2):395-401. PubMed ID: 2987478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors.
    Nimit Y; Schulze I; Cashaw JL; Ruchirawat S; Davis VE
    J Neurosci Res; 1983; 10(2):175-89. PubMed ID: 6313954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lack of affinity of prostaglandins to dopaminergic and opiate receptors in the rat striatum.
    Członkowski A; Herman Z
    Pol J Pharmacol Pharm; 1980; 32(5):639-41. PubMed ID: 6267565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.